Quantcast
Last updated on April 18, 2014 at 9:36 EDT

Latest Sigma Life Science Stories

2013-09-03 08:27:16

Horizon to utilize both nuclease and rAAV gene editing platforms in custom cell-line generation services and creation of genetically-defined cell line products ST. LOUIS, Sept. 3, 2013 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma(®) Life Science, its innovative biological products and services business, has entered a non-exclusive license agreement with Horizon Discovery for use of Sigma's CompoZr(®) Zinc Finger Nuclease (ZFN) technology....

2013-08-27 08:26:43

ST. LOUIS, Aug. 27, 2013 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma(® )Life Science, its innovative biological products and services business, released Sigma CRISPRs, an inexpensive mammalian genome editing tool suitable for screening and exploratory studies. Sigma CRISPRs are packaged in a single plasmid vector containing GFP for fast enrichment of gene-edited cells and can be custom-designed online using an exclusive bioinformatics tool...

2013-04-09 08:30:24

ST. LOUIS, April 9, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that Sigma Life Science, its innovative biological products and services business, has signed an agreement with the Culture Collections of Public Health England, curators for the European Collection of Cell Cultures (ECACC(®)). In the agreement, the ECACC collection of unique, expertly preserved, authenticated human and animal cell cultures will be offered through the powerful Sigma-Aldrich...

2013-02-13 08:27:32

ST. LOUIS, Feb. 13, 2013 /PRNewswire/ -- Sigma-Aldrich((R)) Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, through an exclusive collaboration with Drs. Hideo Iba and Takeshi Haraguchi at the University of Tokyo, released MISSION((R) )Synthetic and Lentiviral microRNA Inhibitors based upon the Tough Decoy (TuD) design for the long-term suppression of any miRNA endogenous to humans or mice. Custom designs for other...

2013-02-12 08:24:09

ST. LOUIS, Feb. 12, 2013 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (NASDAQ: SIAL), a leading Life Science and High Technology Company, announced that Sigma(®) Life Science, its innovative biological products and services business, signed an agreement to distribute worldwide Olink Bioscience's Duolink(®) In Situ products, which present a new disruptive method for imaging and measuring protein-protein interactions in unmodified cells. The Duolink In Situ products work in tandem...

2012-11-20 08:22:35

ST. LOUIS, Nov. 20, 2012 /PRNewswire/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) announced that Sigma Life Science, its innovative biological products and services business, today launched its CompoZr® Transporter Knockout human cell lines in a consumable, assay-ready plate format. The efflux transporter knockout cell lines allow precise identification of individual drug-transporter interactions, a critical component for understanding the safety and efficacy characteristics of drug...

2012-10-16 07:26:23

ST. LOUIS, Oct. 16, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma(®) Life Science, and Ekam Imaging, Inc. have partnered to develop a suite of preclinical services based on the advanced translational power of genetically engineered rat models from SAGE Labs and Ekam's expertise in functional magnetic resonance imaging (fMRI) technology. For more information on SAGE Labs,...

2012-10-15 07:28:25

ST. LOUIS, Oct. 15, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, initiated a licensing program aimed at contract research organizations (CROs) and pharmaceutical companies for its novel CompoZr(®) Transporter Knockout Cell Lines for preclinical ADME screening and safety studies. Complete functional knockouts of transporters in the intestinal cell line...

2012-10-03 02:26:45

ST. LOUIS, Oct. 3, 2012 /PRNewswire/ -- Sigma-Aldrich(®) Corporation (Nasdaq: SIAL) announced today that Sigma Life Science, its innovative biological products and services research business, has launched Stemline(®) Pluripotent Culture Medium, a novel human pluripotent stem cell culture medium that provides a consistent environment for the long-term maintenance and growth of healthy pluripotent stem cells. The new medium performs equivalently to the industry's leading medium and...

2012-08-02 02:30:18

ST. LOUIS, August 2, 2012 /PRNewswire/ -- Sigma-Aldrich(® )Corporation (Nasdaq: SIAL) today announced that Sigma Advanced Genetic Engineering (SAGE) Labs, an initiative of Sigma(®) Life Science and Autism Speaks(®), the nation's largest autism science and advocacy organization, expanded a collaboration to develop the first rat models with modified autism associated genes, intended to accelerate discovery and translational autism research. Expansion of the collaboration follows...